Husseini K. Manji, MD

home / authors / husseini-k-manji-md

Articles

Considering challenges and opportunities in digital health solutions for mental health care.

Digital Health as an Enabler for Patient-Centric, Outcome-Based Care

Vaibhav A. Narayan, PhD;Nawal Roy;Thomas R. Insel, MD;Harris A. Eyre, MD, PhD;Veronica Kelley, DSW;Husseini K. Manji, MD

August 11th 2022

Considering challenges and opportunities in digital health solutions for mental health care.

Smart Growth: the Case for Measuring Brain Capital

Anika Sinha;Rashi Ojha;Erin Smith;William Hynes, DPhil;Cara Altimus, PhD;Sandra Bond Chapman, PhD;Ian Robertson, PhD;Husseini K. Manji, MD;Rym Ayadi, PhD;Harris A. Eyre, MD, PhD

February 18th 2021

Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?

Focus on Bipolar Disorder

Carlos A. Zarate, Jr, MD;Husseini K. Manji, MD

April 16th 2008

Although several antimanic agents are available to treat individuals with bipolar disorder (BD), many patients have a less than satisfactory response or experience adverse effects.1 With the exception of lithium, all of the current antimanic agents are either anticonvulsant or antipsychotic drugs. It is remarkable that no drug has been developed specifically for BD, especially because this illness was conceptualized more than a century ago.